Revive Therapeutics (RVV.C) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. RVV holds 13 patents (issued and…
research and development
Revive Therapeutics (RVV.C) signed a research agreement with the University of California, San Francisco (UCSF) to explore Bucillamine as a potential treatment for severe cases of COVID-19 today, according…
Mind Medicine (MMED.E) announced earlier this week their intention to conduct a randomized placebo-controlled study using LSD to evaluate certain health and cognitive effects according to a press release….
Numinus Wellness (NUMI.V) entered into a lab services agreement with Optimi Health to develop a functional mushroom brand for the health and wellness sector earlier this week, according to…
The Flowr Corp (FLWR.V) and Scots Miracle-Gro Company (SMG.NYSE) subsidiary Hawthorne Canada completed a research and development facility in Kelowna, BC, for cannabis cultivation techniques and systems today, according…
New Wave Holdings (SPOR.C) entered a joint venture with the University of West Indies for drug discovery and improve knowledge of medicinal plants in Jamaica, according to a press…
Alberta-based RMMI (RMMI.C) entered into a partnership with plants genetic tech company, SynerGenetics Bioscience, to develop novel hemp strains with high-CBD content and other hemp-derived cannabinoid cultivars, according to…
Sol Global Investments’ (SOL.C) 40.7% owned subsidiary Heavenly Rx, inked a memorandum of understanding (MOU) today to go public using Therapix Biosciences (TRPX.Q) for their reverse takeover. Sol originally…